Postjunctional alpha 2-adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels

Br J Pharmacol. 1989 Jul;97(3):829-34. doi: 10.1111/j.1476-5381.1989.tb12022.x.

Abstract

1. In vitro studies have been performed on human medium-sized muscular arteries (internal diameter 1-4 mm) in a classical organ bath and with human subcutaneous resistance arteries (internal diameter 103-626 microns) in a microvascular myograph. 2. Although the medium-sized muscular arteries showed no response to either of the alpha 2-agonists B-HT 933 or UK 14304 in concentrations up to 10 microM, the subcutaneous resistance arteries from all regions examined showed well-pronounced and concentration-dependent responses to B-HT 933, the pD2 (-log EC50) being 5.11 +/- 0.09. 3. In the resistance arteries the alpha 2-antagonist yohimbine caused a parallel shift to the right of the B-HT 933 concentration-response curve; the yohimbine pA2 for the B-HT 933 receptor was 7.86 +/- 0.12. 4. There was an inverse relationship between the maximum response to B-HT 933 and the calibre of the resistance vessels. 5. These results indicate the presence of a postjunctional alpha 2-adrenoceptor in human subcutaneous resistance arteries and not in medium sized muscular arteries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / pharmacology
  • Arteries / drug effects
  • Azepines / pharmacology
  • Brimonidine Tartrate
  • Doxazosin
  • Female
  • Humans
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Norepinephrine / pharmacology
  • Prazosin / analogs & derivatives
  • Prazosin / pharmacology
  • Quinoxalines / pharmacology
  • Receptors, Adrenergic, alpha / physiology*
  • Regional Blood Flow / drug effects
  • Skin / blood supply*
  • Vascular Resistance / drug effects
  • Vasoconstriction*
  • Veins / drug effects
  • Yohimbine / pharmacology

Substances

  • Antihypertensive Agents
  • Azepines
  • Quinoxalines
  • Receptors, Adrenergic, alpha
  • Yohimbine
  • Brimonidine Tartrate
  • azepexole
  • Doxazosin
  • Norepinephrine
  • Prazosin